AAD 2026Abstract 73506
Povorcitinib Demonstrates Efficacy in Patients With Chronic Spontaneous Urticaria (CSU) Regardless of Baseline Immunoglobulin E (IgE) Levels or Prior Exposure to Anti-IgE Biologics
Metz M, Bernstein JA, Saini S, Pinter A, Simon JC, Biguenet S, Miller M, Wagya K, Staubach P
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Urticaria
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1379 · Not in PubMed: details from Crossref